# Sanofi (SNY) — Overview

SNY · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sny

## Price

Last close $40.29 on Oct 15, 2026. 52-week range $39.12 – $52.34.

## Company profile

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $56.6B |
| Revenue (quarter) | $14.0B |
| Revenue growth (year over year) | 11.14% |
| Gross profit (trailing twelve months) | $41.2B |
| Gross margin | 72.75% |
| Net income (trailing twelve months) | $4.6B |
| Net income (quarter) | $430.4M |
| Net income growth (year over year) | -90.73% |
| Net margin | 8.17% |
| Return on equity | 5.65% |
| EPS (trailing twelve months) | $1.90 |
| Book value per share | $32.54 |
| P/E (trailing twelve months) | 21.4 |
| Price to book | 1.2 |
| Debt to assets | 46.10% |
| Payout ratio | 61.10% |
| Dividend yield | 5.01% |

## Frequently Asked Questions

### Is Sanofi (SNY) profitable?

Yes. Sanofi earned $4.6B in net income over the trailing twelve months, a net margin of 8.17%.

### How much revenue does Sanofi (SNY) make?

Sanofi generated $56.6B in revenue over the trailing twelve months, up 11.14% year over year.

### What is SNY's P/E ratio?

Sanofi trades at 21.4 times trailing twelve-month earnings, on an EPS of $1.90.

### How do I buy stock in Sanofi (SNY)?

SNY trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).